About
Driving Genome Editing Therapeutics Forward
Cassidy Bio is an AI-first biotechnology company building the first programmable platform for gene editing. Cassidy Bio replaces the narrow, trial-and-error design process with large-scale prediction, simulation, and in silico validation, powered by genomic foundation models trained on proprietary biological data. The platform scales to connect across multiple components guides, editing systems, delivery systems and variant backgrounds ranking designs by safety and efficacy. Cassidy Bio’s vision is to enable not just one-off miracles, but a new generation of reliable gene editing therapies at scale.
Identity
| Name | Cassidy Bio |
|---|---|
| Slug | cassidy-bio |
| Former names | TakenOti |
| Type / kind | startup |
| Source _id | 99PwOyKTmUYnxrxJwdRBwFdylADWyHkQKNTLMqnVS6uXKGVEZpeyWX |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Tel Aviv-Yafo, Israel |
Web & social
| Website | https://www.cassidybio.com |
|---|---|
| Careers page | https://www.cassidy-bio.comcareers |
| https://www.linkedin.com/company/104632479 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business models
B2B
Tags
pharmaceuticalsgenome-editingtherapeuticsbiotechnology
Funding
| Total raised | $8.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}